2013 to 2016 Saw No Change in Antibiotic Prescribing Practices

Share this content:
2013 to 2016 Saw No Change in Antibiotic Prescribing Practices
2013 to 2016 Saw No Change in Antibiotic Prescribing Practices

FRIDAY, March 16, 2018 (HealthDay News) -- From 2013 to 2016, annual national outpatient antibiotic prescribing practices remained unchanged, according to a study published online Feb. 27 in Infection Control & Hospital Epidemiology.

Michael J. Durkin, M.D., M.P.H., from the Washington University School of Medicine in St. Louis, and colleagues characterized trends in outpatient antibiotic prescribing in the United States from 2013 to 2015. National administrative claims data from a pharmacy benefits manager were obtained.

The researchers found that during the three-year study period, about 98 million outpatient antibiotic prescriptions were filled by 39 million insurance beneficiaries. Azithromycin, amoxicillin, amoxicillin/clavulanate, ciprofloxacin, and cephalexin were the most commonly prescribed antibiotics. During the study period there were no significant changes in individual or overall annual antibiotic prescribing rates. There was significant seasonal variation, with antibiotics 42 percent more likely to be prescribed during February than September (peak-to-trough ratio [PTTR], 1.42). Seasonal trends were similar for azithromycin, amoxicillin, and amoxicillin/clavulanate (PTTRs, 2.46, 1.52, and 1.78, respectively).

"These results suggest that inappropriate prescribing of antibiotics remains widespread, despite the concurrent release of several guideline-based best practices intended to reduce inappropriate antibiotic consumption; however, further research linking national outpatient antibiotic prescriptions to associated medical conditions is needed to confirm these findings," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

8 More U.S. Communities to Be Assessed for PFAS Toxin Exposure

8 More U.S. Communities to Be Assessed for ...

Assessments will lay groundwork for future study of the health effects of perfluoroalkyl, polyfluoroalkyl

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

Proposed rule will help consumers better understand what the sunscreens they are buying can actually do

U.S. Agencies Probing Johnson  Johnson Over Asbestos in Talc

U.S. Agencies Probing Johnson & Johnson Over Asbestos ...

Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma

is free, fast, and customized just for you!




Already a member?

Sign In Now »